Join to view full profile
13400 E Shea BlvdScottsdale, AZ 85259
Phone+1 480-301-8000
Dr. Bahadur is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Louisiana State University School of MedicineFellowship, Hematology and Medical Oncology, 2008 - 2011- Louisiana State University School of MedicineResidency, Internal Medicine, 2005 - 2008
St Christopher's College of MedicineClass of 2004
Certifications & Licensure
AZ State Medical License 2011 - 2027
LA State Medical License 2008 - 2013
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MEDSEEK Empower, SymphonyCare, LLC, 2014, 2016
- CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2014, 2016
- CMS Meaningful Use Stage 1 Certification PowerChart (CQM), Cerner Corporation, 2014, 2016
Clinical Trials
- Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy Start of enrollment: 2019 Sep 23
Roles: Principal Investigator, Contact
- Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer Start of enrollment: 2007 Apr 17
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 1 citationsQualitative Interviews on the Experience of Orally vs. Intramuscularly Administered Endocrine Therapy for Advanced Breast Cancer: Patient and Healthcare Provider Persp...Rebecca M Speck, Gale Harding, Aarti R Chawla, Christine R Agius, Shakeela W Bahadur
Oncology and Therapy. 2026-03-01 - 128 citationsThe PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial.Jason J Luke, Manish R Patel, George R Blumenschein, Erika Hamilton, Bartosz Chmielowski
Nature Medicine. 2023-11-01 - 31 citationsImmunotherapy for the Treatment of Breast Cancer: Emerging New DataLida A. Mina, Shannon Lim, Shakeela W Bahadur, Abdul T Firoz
Breast Cancer. 2020-01-03
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: